In the PPI network of gene targets of DSD for the treatment of MI, TP53 (p53), EGFR, AKT1, STAT3, IL6, IL1B, SRC, and MYC are in central positions, indicating that they may be key targets for MI treatment. The gene discussed is EGFR; the disease is disorder of sexual differentiation.